These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 778275)

  • 21. Macrophage migration inhibition factor (MIF): reducing the variables.
    MacSween JM; Rajaraman K; Rajaraman R; Fox RA
    J Immunol Methods; 1982; 52(1):127-36. PubMed ID: 6288804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
    Scott DM; McConnell I; Agomo P; Lachmann PJ
    Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification of a lymphoid cell line product with leukocyte inhibitory factor activity.
    Meshulam DH; Blair HE; Wong BL; Charm S; Minowada J; Rocklin RE
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):601-5. PubMed ID: 6952211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
    Rocklin RE
    J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification of guinea pig pH 3 migration inhibitory factor.
    Remold HG; McCarthy PL; Mednis AD
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4088-91. PubMed ID: 7027252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage migration inhibition induced by MDP, LPS, PMA, and MIF/MAF: reversal by macrophage migration enhancement factor (MEF), L-fucose, L-fucosyl BSA, D-mannose, and D-mannosyl BSA.
    Gordon MR; Chida K; Takata I; Myrvik QN
    J Leukoc Biol; 1987 Sep; 42(3):197-203. PubMed ID: 3305746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human leukocyte inhibitory factor (LIF): use of benzoyl L-arginine ethyl ester to detect LIF activity.
    Rocklin RE; Urbano AM
    J Immunol; 1978 Apr; 120(4):1409-14. PubMed ID: 347003
    [No Abstract]   [Full Text] [Related]  

  • 28. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 29. [Factor inhibiting leukocyte migration in the blood serum of patients with pneumonia as one of the criteria of transition of the process into chronic state].
    Novikova VI; Novikov DK
    Pediatriia; 1978 Apr; (4):19-23. PubMed ID: 349497
    [No Abstract]   [Full Text] [Related]  

  • 30. [Purification of the cholestatic factor by a gel filtration using Sephadex G-75 column and deae-cellulose column chromatography (author's transl)].
    Mizoguchi Y; Ohnishi F; Shiba T; Higashimori T; Monna T; Yamamoto S; Morisawa S
    Nihon Shokakibyo Gakkai Zasshi; 1980 Jul; 77(7):1083-8. PubMed ID: 6997580
    [No Abstract]   [Full Text] [Related]  

  • 31. The structure and physicochemical properties of rat liver macrophage migration inhibitory factor.
    Nishihira J; Kuriyama T; Sakai M; Nishi S; Ohki S; Hikichi K
    Biochim Biophys Acta; 1995 Feb; 1247(1):159-62. PubMed ID: 7873586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. I. Biochemical characterization and purification.
    Fahlbusch B; Tittel R
    Biomed Biochim Acta; 1986; 45(3):359-70. PubMed ID: 3518710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The indirect assay for leukocyte migration inhibitory factor (LIF)--standardization and the effect of pH.
    Willoughby EW; Dupont B; Hansen JA; Good RA
    J Immunol Methods; 1978; 22(1-2):99-110. PubMed ID: 27562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial purification and characterization of a human lymphokine which induces antileishmanial activity in mouse macrophages.
    Buchmuller Y; Weiser WY; Remold HG
    Cell Immunol; 1985 Jan; 90(1):242-50. PubMed ID: 3881189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage migration inhibitory factor (MIF) produced by a human T cell hybridoma clone.
    Oki S; Hirose S; Higuchi M; Osawa T
    Lymphokine Cytokine Res; 1991 Aug; 10(4):273-80. PubMed ID: 1932371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation.
    Oyama R; Yamamoto H; Titani K
    Biochim Biophys Acta; 2000 Jun; 1479(1-2):91-102. PubMed ID: 11004532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-fucose blocks MIF/MAF priming of rabbit alveolar macrophages for a PMA-induced oxidative response.
    Umehara K; Hayakawa H; Myrvik QN
    Cell Immunol; 1989 Mar; 119(1):67-72. PubMed ID: 2646027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial purification and chemical characterization of macrophage cytotoxicity factor (MCF, MAF) and its separation from migration inhibitory factor (MIF).
    Kniep EM; Domzig W; Lohmann-Matthes ML; Kickhöfen B
    J Immunol; 1981 Aug; 127(2):417-22. PubMed ID: 6166671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial purification of human leucocyte migration inhibitory factor (LIF) by immunosorption of supernatant protein contaminants detected by crossed immunoelectrophorsis.
    Bendtzen K
    J Immunol Methods; 1976; 13(3-4):321-31. PubMed ID: 796389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies.
    Berg K; Ogburn CA; Paucker K; Mogensen KE; Cantell K
    J Immunol; 1975 Feb; 114(2 Pt 1):640-4. PubMed ID: 1168221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.